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Abstract 
Background: Antimicrobial resistance is a global public health challenge and carbapenem resistance, in particular, is 
considered an urgent global health threat. This study was carried out to give a bibliometric overview of literature on 
carbapenem resistance. In specific, number of publications, top productive countries and institutes, highly cited arti‑
cles, citation analysis, co‑authorships, international collaboration, top active authors, and journals publishing articles 
on carbapenem resistance were analyzed and discussed.
Methods: Specific keywords pertaining to carbapenem resistance were used in Scopus database. Quantitative and 
qualitative analysis of retrieved data were presented using appropriate bibliometric indicators and visualization maps.
Results: A total of 2617 journal articles were retrieved. The average number of citations per article was of 21.47. The 
growth of publications showed a dramatic increase from 2008 to 2015. Approximately 9 % of retrieved articles on 
carbapenem resistance were published in Antimicrobial Agents and Chemotherapy journal. Retrieved articles were 
published by 102 different countries. The United States of America (USA) contributed most with 437 (16.70 %) articles 
followed by China with 257 (9.82 %) articles. When productivity was stratified by population size, Greece ranked 
first followed by France. Greece also ranked first when data were stratified by gross domestic product (GDP). Asian 
countries have lesser international collaboration compared with other countries in the top ten list. Five of top ten 
productive institutes were Europeans (France, the UK, Greece, Italy, and Switzerland) and two were Asians (China and 
South Korea). Other active institutes included an Israeli and a Brazilian institute. Four of the top ten cited articles were 
published in Antimicrobial Agents and Chemotherapy journal and two were published in The Lancet Infectious Diseases.
Conclusion: There was a dramatic increase in number of publications on carbapenem resistance in the past few 
years. These publications were produced from different world regions including Asia, Europe, Middle East, and Latin 
America. International collaboration needs to be encouraged particularly for researchers in Asia. Molecular biology 
and epidemiology dominated the theme of the top ten cited articles on carbapenem resistance. This bibliometric 
study will hopefully help health policy makers in planning future research and allocating funds pertaining to carbap‑
enem resistance.
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Background
In 2014, the World Health Organization (WHO) issued 
a report on antimicrobial resistance (AMR) stating that 
AMR is becoming a global challenge that threatens the 
clinical benefit of many important antimicrobial agents 
[1]. Of a real concern in the WHO report was a warning 
about spread of resistance among different Gram-nega-
tive bacteria to carbapenems. This created a great deal of 
concern among clinicians, microbiologists and pharma-
cologists because carbapenems are considered antibiotics 
of last resort in combating serious infections [2]. Carbap-
enems are β-lactam antibiotics that were developed from 
thienamycin, which served as the parent model for other 
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carbapenems including imipenem, ertapenem, dorip-
enem and meropenem [3, 4]. Carbapenem resistance is 
a global public health challenge and efforts to minimize 
the spread of carbapenem resistance and risk of serious 
outbreaks is considered top priority [5, 6]. International 
health organizations, governments, healthcare providers, 
and researchers need to coordinate efforts and respond 
to this new global public health challenge by implement-
ing programs to rationalize use of antibiotics [7–9]. As a 
baseline information, it is important to analyze research 
output published globally on carbapenem resistance. 
Such baseline data are needed in order to understand 
the current research situation and plan future research 
agenda accordingly.
An important and common method used to assess 
research activity on a certain topic is bibliometric analy-
sis which is defined as the use of mathematical methods 
to analyze published articles in terms of quantity and 
quality [10, 11]. In bibliometric analysis, information 
regarding growth of publications, international collabo-
ration, top active countries, institutes, and authors are 
presented. Moreover, journals publishing on the topic of 
interest are also presented. In some bibliometric studies, 
maps are presented as a method of visualization of bib-
liometric indicators. The retrieval of published articles 
on a certain topic is the first step in evaluation of litera-
ture regarding a certain problem or topic and in building 
evidence based clinical decisions. Retrieval of published 
articles on a certain topic can be achieved through the 
use of databases like PubMed, Google Scholar, Scopus, 
or Web of Science. In the past decade, a number of bib-
liometric studies on specific types of infections and on 
specific types of medical subjects like microbiology were 
published [12–14]. However, no bibliometric studies have 
been carried out on carbapenem resistance. Therefore, 
this study was carried out to analyze and present biblio-
metric indicators pertaining to literature on carbapenem 
resistance.
Methods
Data collection for this study was carried out using Sco-
pus database. The methodology used was similar to that 
described in previously published bibliometric stud-
ies [15–21]. Keywords used for data extraction were 
obtained from published review articles on carbapenem 
resistance. Search query used for data extraction from 
Scopus looked like this:
(TITLE(“carbapenem resist*” OR “imipenem resist*” 
OR “meropenem resist*” OR “ertapenem resist*” OR 
“doripenem resist*” OR “carbapenemase produ*” OR “car-
bapenem non-susceptible” OR “carbapenem hdroly*ing”) 
AND PUBYEAR < 2016) OR ((TITLE-ABS-KEY(Ndm-1 
OR “New Delhi metallo*” OR “carbapenemase” OR 
“extended-spectrum *lactamase*”) AND TITLE-
ABS(“carbapenem resist*”)) OR ((TITLE (“coli” OR 
“enterobacter*” OR “aeruginosa” OR “baumannii” OR 
“klebsiella”)) AND KEY(“carbapenem resist*”)) AND 
PUBYEAR  <  2016) AND (LIMIT-TO(SRCTYPE,”j”)) 
AND (EXCLUDE(DOCTYPE,”er”))
The asterisk was used for certain words to retrieve all 
potential correct words while the quotation marks were 
used to retrieve correct and exact phrases. Validity of the 
search query was confirmed by manual analysis of the 
top 100 cited articles. In this study, manual analysis of the 
top 100 cited articles showed no deviation from required 
goal of retrieving articles on carbapenem resistance. The 
time span for data collection was all previous years until 
2015. Retrieved documents were refined and limited to 
journal articles. Errata and undefined documents were 
excluded. Bibliometric indicators were presented as top 
ten productive countries, institutes, authors, journals, 
and highly cited articles. For evaluation of quality of pub-
lications, h-index, average number of citations per arti-
cle, and total number of citations were used [13, 22–25]. 
For quality of journals publishing articles on carbapenem 
resistance, impact factor (IF) and scientific journal rank-
ings (SJR) were presented for each journal. Impact factors 
for journals were obtained from the latest Journal Cita-
tion Report published by Thompson Reuters [26] while 
SJR for journals were obtained from Scimago Journal 
Rank [27]. Poisson loglinear regression was carried out 
using the annual worldwide productivity as a dependent 
variable. Predictor independent variables were used as 
covariates in the model. The covariates were: number of 
publications produced annually by top three countries, 
number of articles with the keyword “hospital”, and num-
ber of articles produced annually in the field of molecu-
lar biology/microbiology. Author co-citation analysis 
(ACA) was presented as density visualization map using 
VOSviewer techniques [28].
Results
A total of 2617 articles were retrieved. The average number 
of citations per article was 21.47. The h-index of retrieved 
articles was 102. Most retrieved documents were original 
articles (2126, 81.24 %) and most of these documents were 
written in English language (2355, 89.99 %). Chinese lan-
guage ranked second with 120 (4.59 %) articles. Growth of 
publications on carbapenem resistance started in 1986 and 
remained at an average of ten articles per year until late 
1990s. Growth of publications increased slowly from 2000 
to 2008 followed by a dramatic rise in the number of pub-
lications (Fig. 1). The oldest articles on carbapenem resist-
ance were published in 1986. These old articles discussed 
imipenem resistance in Pseudomonas aeruginosa and Bac-
teroides fragilis [29–31].
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There was a linear increase in number of publications 
with time. However, the number of citations per article 
per year showed an inverse linear relationship with time 
indicating that older articles were being continuously 
cited with time (Fig. 2).
Relevant terms to carbapenem resistance were ana-
lyzed for number of occurrences in article titles using 
VOSviewer technique. Analysis showed that “pneumo-
niae” was the most frequent term (305 occurrences) fol-
lowed by “Acinetobacter baumannii” (302 occurrences), 
“Pseudomonas aeruginosa” (132 occurrences), “resistant 
Enterobacteriaceae” (124 occurrences), and “metallo β 
lactamase” (21 occurrences).
Core journals that published most on carbapenem resist-
ance were shown in Table 1. A total of 1078 (41 %) articles on 
carbapenem resistance were published by top ten journals 
listed in Table 1. Approximately 9 % (n = 232) of retrieved 
articles on carbapenem resistance were published in Anti-
microbial Agents and Chemotherapy journal (IF of 4.476). 
Journals in the top ten list were in the field of antimicrobials, 
microbiology, infection, and antimicrobial resistance. Fur-
thermore, all journals in the top ten list were prestigious and 
influential ones. The journal with the highest IF was Journal 
of Antimicrobial Chemotherapy (IF = 5.313).
Retrieved articles were published by 102 different 
countries distributed in all world regions. However, 
68.44 % (n = 1791) of retrieved articles were published by 
top ten ranking countries. The list of top ten productive 
countries included five countries in Europe, three in Asia, 
one in Northern America, and one in Latin America 
(Table  2). The United States of America (USA) had the 
greatest contribution with 437 (16.70 %) articles followed 
by China with 257 (9.82  %) articles. When productivity 
was stratified by population size, Greece ranked first fol-
lowed by France. However, when productivity was strati-
fied by gross domestic product (GDP), Greece ranked 
first followed by Spain. When quality of publications 
was assessed for each country by calculating the average 
number of citations per article, the United Kingdom (UK) 
ranked first followed by Greece and France. International 
collaboration, assessed by the number of articles with 
multiple country affiliations, showed that UK had the 
highest percentage of articles with international collabo-
ration (82; 54.92 %) followed by France (117; 53.92 %) and 
Greece (40; 38.46  %). Top three countries (UK, France 
and Greece) engaged in international collaboration were 
the same top three countries which had the highest aver-
age number of citations per article.
Using Poisson loglinear regression, we examined vari-
ations of three factors on the annual number of publi-
cations on carbapenem resistance. The variables tested 
were (1) “hospital” as a keyword in the article; (2) subject 
Fig. 1 Temporal distribution of production of publications about carbapenem resistance (1986–2015)
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Fig. 2 Growth of publications and citations for carbapenem resistance (1986–2015)
Table 1 Top ten journals publishing on carbapenem resistance (1986–2015)
SCR standard competition ranking, SJR scientific journal rank, IF impact factor, R rank
SCR Journal Number of articles 
(%)




h-index (R) IF (R) SJR (R)
1st Antimicrobial Agents and 
Chemotherapy (USA)
232 (8.87) 12,136 (1) 52.31 (1) 57 (1) 4.476 (3) 2.01 (2)
2nd Journal of Antimicrobial 
Chemotherapy (USA)
201 (7.68) 7245 (2) 36.04 (3) 51 (2) 5.313 (1) 1.98 (3)
3rd Journal of Clinical Microbiol-
ogy (USA)
119 (4.55) 4502 (3) 22.40 (6) 39 (3) 4.232 (5) 1.89 (4)
4th International Journal of 
Antimicrobial Agents 
(Netherlands)
101 (3.86) 2777 (5) 23.34 (5) 27 (6) 4.269 (4) 1.28 (6)
5th Clinical Microbiology and 
Infection (UK)
85 (3.04) 3079 (4) 37.55 (2) 30 (4) 5.197 (2) 2.29 (1)
6th Infection Control and Hospi-
tal Epidemiology (USA)
84 (3.21) 2403 (6) 23.79 (4) 28 (5) 4.175 (6) 1.80 (5)
7th Diagnostic Microbiology and 
Infectious Disease (USA)
82 (3.13) 1163 (7) 13.85 (8) 20 (7) 2.457 (9) 1.02 (8)
8th Journal of Medical Microbiol-
ogy (UK)
66 (2.52) 956 (8) 11.25 (9) 19 (8) 2.248 (10) 0.91 (9)
9th Microbial Drug Resistance 
(USA)
56 (2.14) 642 (10) 9.73 (10) 15 (10) 2.490 (8) 0.91 (9)
10th Journal of Hospital Infection 
(UK)
52 (1.99) 937 (9) 16.73 (7) 16 (9) 2.544 (7) 1.05 (7)
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area in the field of molecular biology/microbiology; and 
(3) annual productivity of top three countries. Variables 
were entered in Poisson regression model as continuous 
covariates. Table 3 shows that molecular biology/micro-
biology subject area (p  <  0.01) and presence of article 
keyword “hospital” (p  <  0.01) were significant predic-
tors of worldwide research productivity on carbapenem 
resistance. The results indicated that the worldwide pro-
ductivity will be 1.002 times greater for each extra article 
published in the field of molecular biology/microbiology. 
Similarly, the worldwide productivity will be 1.031 times 
greater for each extra article published with a keyword 
“hospital”. The annual productivity of the top three coun-
tries was not a significant predictor (p = 0.296) of world-
wide research productivity on carbapenem resistance.
Research and academic institutes involved in carbap-
enem resistance were presented as top ten productive 
institutes in Table 4. Five of top ten productive institutes 
were in Europe (France, Greece, UK, Italy and Switzer-
land) and two were in Asia (China and South Korea). 
Other active institutes were ones in the USA, Israel and 
Brazil. When ranked based on the number of published 
articles, Hopital de Bicetre in France ranked first followed 
by the University of Athens Medical School in Greece, 
Zhejiang University in China, VA medical center in the 
USA and Health Protection Agency in the UK. However, 
when top ten productive institutes were ranked based 
on quality of publications assessed by average number of 
citations per article, Health Protection Agency in the UK 
ranked first followed by Centers for Disease Prevention 
and Control (CDC) in the USA. At least three of top ten 
institutes were governmental health research institutes 
(VA Medical Center, CDC and Health Protection Agency).
Active researchers in the field of carbapenem resistance 
are shown in Table 5 as top ten active authors. Professor 
Nordmann ranked first in number and quality of publi-
cations with 95 publications and h-index of 36. Profes-
sor Poirel ranked second in number of publications with 
71 publications and h-index of 32 while Carmeli ranked 
third with 47 publications and h-index of 26. Both Nor-
dman and Poirel are affiliated with the same institute 
(Inserm U914, Kremlin-Bicêtre, France and Départe-
ment de médecine, Faculté des sciences, Université de 
Fribourg, Fribourg, Switzerland). Both professors have 
extensive research collaboration. Same applies to Pro-
fessors Carmeli and Navon-Venezia who share the same 
affiliation and have a noticeable research collaboration. 
Table 2 Top ten productive countries on carbapenem publications (1986–2015)
SCR standard competition ranking, GDP gross domestic product
a Percentage of documents with international authors was calculated by dividing number of documents with international authors by the total number of documents 
retrieved for the country assigned
























1st United States 437 (16.70) 13.70 (7) 25.09 (9) 14,667 (1) 33.56 (4) 62 (1) 39 145 (33.18)
2nd China 257 (9.82) 1.88 (9) 24.83 (10) 2069 (9) 8.05 (10) 23 (7) 16 29 (11.28)
3rd France 217 (8.29) 32.77 (2) 76.71 (3) 7835(3) 36.11 (3) 45 (3) 55 117 (53.92)
4th United King‑
dom
151 (5.77) 23.39 (5) 50.52 (8) 8909 (2) 59.00 (1) 49 (2) 57 82 (54.92)
5th Italy 146 (5.58) 24.02 (4) 68.19 (5) 3900 (4) 26.71 (7) 31 (5) 43 44 (30.14)
6th India 137 (5.24) 1.06 (10) 66.86 (6) 2407 (8) 17.57 (8) 19 (10) 21 16 (11.68)
7th Brazil 125 (4.78) 6.07 (8) 51.72 (7) 1781 (10) 14.25 (9) 21 (9) 10 22 (17.60)
8th Spain 118 (4.51) 25.39 (3) 85.45 (2) 3192 (6) 27.05 (6) 31 (5) 36 24 (20.34)
9th Greece 104 (3.97) 95.68 (1) 441.43 (1) 3778 (5) 36.33 (2) 37 (4) 39 40 (38.46)
10th South Korea 99 (3.78) 19.55 (6) 70.21 (4) 2896 (7) 29.25 (5) 23 (7) 15 12 (12.12)
Table 3 Poisson loglinear regression model for predicting 
worldwide research productivity on  carbapenem resist-
ance
Dependent variable: worldwide productivity. Model: Hospital, Molecular, and 
productivity by top three countries
B coefficient estimates, Exp(B) exponentiated values of the coefficients





(Intercept) 3.058 0.000 21.277 19.621 23.072
Productivity by top three 
countries
−0.001 0.296 0.999 0.996 1.001
Hospital 0.030 0.000 1.031 1.027 1.034
Molecular 0.004 0.001 1.004 1.002 1.006
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Six of top ten active authors on carbapenem resistance 
were in Europe, two in Israel, one in the USA and one in 
South Korea.
Author co-citation analysis (ACA) for top ten active 
authors was carried out using VOSviewer technique. 
The ultimate number of authors included was 28 based 
on a minimum number of 100 citations per author. The 
map produced included 28 authors distributed into three 
clusters (red, green, and blue) as shown in Fig.  3. Clus-
ter number one included 13, cluster two included 11, and 
cluster three included four authors. Some of the authors 
might not be shown clearly in the map because some of 
the names were overlapping.
The following top active authors were present in cluster 
number one (red) and were commonly co-cited together: 
Woodford, Livermore, Tsakris and Lee. Cluster number 
two (green) included the following top active authors: 
Carmeli, Bonomo, and Navon-Venezia. Cluster number 
three (blue) included the following top active authors: 
Nordmann and Poirel.
In cluster number two (green), both Carmeli and 
Navon-Venezia are Israeli researchers, the former is in 
the field of molecular biology and the latter is in the field 
of preventive medicine. It is also noteworthy that both 
Nordman and Poirel (blue cluster) are affiliated with the 
same institute.
Table 4 Top ten list of institutes publishing on carbapenem resistance (1896–2015)
SCR standard competition ranking
a Equal institutes have the same ranking number









1st Hopital de Bicetre 53 (2.03) 3254 (2) 61.40 (3) 25 (2) France
2nd University of Athens Medical 
School
45 (1.72) 1917 (4) 42.60 (6) 23 (3) Greece
3rd Zhejiang University 43 (1.64) 1105 (7) 25.70 (8) 18 (7) China
4th VA Medical Center 39 (1.49) 965 (8) 24.74 (9) 18 (7) United States
5th Health Protection Agency 35 (1.33) 4392 (1) 125.49 (1) 26 (1) United Kingdom
6th Tel Aviv Sourasky Medical 
Center
34 (1.30) 1900 (5) 55.88 (4) 22 (4) Israel
7th Universita degli Studi di Siena 33 (1.26) 1792 (6) 54.30 (5) 19 (5) Italy
8th Centers for Disease Control and 
Prevention
32 (1.22) 2238 (3) 69.94 (2) 19 (5) United States
9th Yonsei University College of 
Medicine
31 (1.18) 803 (9) 25.90 (7) 15 (9) South Korea
10th Universidade Federal de Sao 
Paulo
29 (1.11) 620 (10) 21.38 (10) 11 (11) Brazil
10th Universite de Fribourg 29 (1.11) 452 (11) 15.59 (11) 13 (10) Switzerland
Table 5 Top ten authors publishing on carbapenem resistance (1986–2015)
R rank, SCR standard competition ranking
a Equal authors have the same ranking number, and then a gap is left in the ranking numbers
SCRa Author Number of published articles Color (number of cluster) Total citation (R) h-index (R) Country
1st Nordmann 95 Blue (3) 5545 (1) 36 (1) Switzerland/France
2nd Poirel 71 Blue (3) 4129 (4) 32 (3) Switzerland/France
3rd Carmeli 47 Green (2) 2449 (5) 26 (5) Israel
4th Woodford 44 Red (1) 5083 (3) 32 (3) United Kingdom
5th Livermore 40 Red (1) 5420 (2) 33 (2) United Kingdom
6th Tsakris 36 Red (1) 1075 (9) 18 (8) Greece
7th Bonomo 35 Green (2) 1038 (10) 18 (8) United States
8th Rossolini 35 Red (1) 2010 (6) 19 (7) Italy
9th Lee 35 Red (1) 1708 (7) 17 (10) South Korea
10th Navon‑Venezia 30 Green (2) 1533 (8) 21 (6) Israel
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Top ten cited articles on carbapenem resistance were 
shown in Table 6 [32–41]. Four of the top ten cited arti-
cles were published in Antimicrobial Agents and Chem-
otherapy journal and two were published in The Lancet 
Infectious Diseases. The article that received the highest 
number of citations was “Emergence of a new antibiotic 
resistance mechanism in India, Pakistan, and the UK: A 
molecular, biological, and epidemiological study”. It was 
published in 2010 and received a total of 1212 citations. 
Carbapenem resistance in Klebsiella pneumoniae was 
mentioned in the title of five top cited articles. Professors 
Poirel and Nordmann had good contribution to top ten 
cited articles.
Discussion
In this study, a bibliometric overview of worldwide 
publications on carbapenem resistance was presented. 
Extensive research review showed that few studies were 
published on bibliometrics of carbapenems. These stud-
ies were published in Chinese journals and in Chinese 
language. These Chinese studies were specific to a cer-
tain type of bacteria or specific to New-Delhi metallo 
β-lactamase gene responsible for carbapenem resistance 
[42–44]. Our study is the first bibliometric study pub-
lished in English.
The steep rise in number of publications on carbap-
enem resistance reflects real concern of scientific and 
medical committees about this issue and reflects the 
fact that the problem is spreading across the world [37, 
45–48]. The CDC considers Enterobacteriaceae carbap-
enem resistance as an urgent threat [49]. Despite the fact 
that carbapenem resistance is relatively a recent topic, 
the h-index of retrieved articles was 104 which indicates 
that carbapenem resistance is a very attractive and inter-
esting topic to many readers in the scientific and clinical 
field. Furthermore, the fact that approximately 10  % of 
retrieved documents were written in non-English lan-
guage is a proof of the clinical and research popularity of 
carbapenem resistance.
The core journals publishing articles on carbapenem 
resistance are well-known and prestigious ones in the 
field of microbiology and infection. The majority of core 
journals publishing on carbapenem resistance had an IF 
≥4. It is also interesting to note that one of the core jour-
nals was in specific field of drug resistance. In fact, there 
are at least five international journals being specialized 
in antimicrobial resistance such as “Microbial Drug 
Resistance”, “Journal of Global Antimicrobial Resistance”, 
and “Infection and Drug Resistance”. The core journals 
were mainly those issued in the USA and the UK. This 
explains why the majority of retrieved articles on car-
bapenem resistance were written in English language. 
No doubt, that there was a tremendous effort of Chinese 
researchers to publish on carbapenem resistance. How-
ever, Chinese journals are still behind on the interna-
tional arena.
Fig. 3 Author co‑citation analysis for carbapenem resistance publications (1986–2015). Minimum of 100 citations per author, 28 authors were 
included
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Contribution of various countries to publications on 
carbapenem resistance showed that Asian countries 
(China, India and South Korea) had the lowest extent of 
international collaboration. This might explain the low 
number of citations per article published from these 
countries. A study showed that international collabo-
ration increases the chances of citations [50, 51]. The 
result that Greece and France ranked top when results 
were stratified by GDP or population size was surprising. 
Greece had suffered serious outbreaks of infections that 
were resistant to carbapenems and that led to a series of 
publications on this topic [52, 53]. Similar situation hap-
pened in France [54–56].
List of top productive institutes included Tel Aviv 
Sourasky Medical Center (Israel) and Universite de 
Fribourg (Switzerland). However, neither Israel nor 
Switzerland were listed in the top ten productive coun-
tries. Several hospitals in Israel had suffered from serious 
outbreaks of infections resistant to carbapenems [57–
59]. These outbreaks of infections that threatened many 
Israeli hospitals has led researchers in Israel to pub-
lish reports on carbapenem resistance. This also might 
explain why two of top ten active authors were affiliated 
with Israeli institutes.
Two articles in the top ten cited articles discussed the 
emergence of New Delhi metallo-β-lactamase (NDM) 
gene responsible for carbapenem resistance. This gene 
belongs to carbapenemase gene family and bacteria car-
rying this gene are referred to as superbugs because they 
are resistant to most antibiotics. The term “New Delhi” 
was given to the gene because the bacteria having this 
gene was initially isolated from a patient who was visiting 
Table 6 Top ten cited articles on carbapenem resistance (1986–2015)
SCR standard competition ranking
SCR Authors Title Year Source title Number of citations
1st Kumarasamy et al. [34] Emergence of a new antibiotic resistance 
mechanism in India, Pakistan, and the 
UK: a molecular, biological, and epide‑
miological study
2010 The Lancet Infectious Diseases 1212
2nd Yong et al. [41] Characterization of a new metallo‑β‑
lactamase gene, bla NDM‑1, and a novel 
erythromycin esterase gene carried on 
a unique genetic structure in Klebsiella 
pneumoniae sequence type 14 from 
India
2009 Antimicrobial Agents and Chemotherapy 835
3rd Nordmann et al. [36] The real threat of Klebsiella pneumoniae 
carbapenemase‑producing bacteria
2009 The Lancet Infectious Diseases 689
4th Yigit et al. [40] Novel carbapenem‑hydrolyzing 
β‑lactamase, KPC‑1, from a carbap‑
enem‑resistant strain of Klebsiella 
pneumoniae
2001 Antimicrobial Agents and Chemotherapy 673
5th Nordmann et al. [37] Global spread of carbapenemase produc‑
ing Enterobacteriaceae
2011 Emerging Infectious Diseases 643
6th Poirel and Nordmann 
[38]
Carbapenem resistance in Acinetobacter 
baumannii: mechanisms and epidemiol‑
ogy
2006 Clinical Microbiology and Infection 474
7th Woodford et al. [39] Multiplex PCR for genes encoding preva‑
lent OXA carbapenemases in Acineto-
bacter spp.
2006 International Journal of Antimicrobial 
Agents
427
8th Lauretti et al. [35] Cloning and characterization of bla(VIM), 
a new integron‑borne metallo‑β‑
lactamase gene from a Pseudomonas 
aeruginosa clinical isolate
1999 Antimicrobial Agents and Chemotherapy 395
9th Bratu et al. [33] Rapid spread of carbapenem‑resistant 
Klebsiella pneumoniae in New York City: 
a new threat to our antibiotic armamen‑
tarium
2005 Archives of Internal Medicine 372
10th Bradford et al. [32] Imipenem resistance in Klebsiella pneumo-
niae is associated with the combination 
of ACT‑1, a plasmid‑mediated AmpC 
β‑lactamase, and the loss of an outer 
membrane protein
1997 Antimicrobial Agents and Chemotherapy 358
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India [41]. This gene made carbapenem resistance an 
alarming risk that could spread worldwide by travelers 
across different parts of the world [60]. The article that 
first characterized this gene became one of the top ten 
cited articles on carbapenem resistance field. Immedi-
ately after publication of this article, an epidemiological 
study with molecular and biological characterization of 
NDM-1 gene in Enterobacteriaceae in India, Pakistan, 
and the UK was published and soon became one of the 
top ten cited articles in the field.
Our study has the advantage of being the first to give 
a bibliometric overview on carbapenem resistance. We 
did our best to include all potential articles and to avoid 
false positive and false negative results. The validation 
method implemented by the external microbiologist did 
confirm accuracy of retrieved data. However, the search 
query itself might not be conclusive and some articles on 
carbapenem resistance might be missed. Furthermore, 
it seems that there are Chinese medical journals that 
not indexed in Scopus and therefore some of the Chi-
nese articles on carbapenem resistance might be missed. 
Therefore, presentation of Chinese scientists in this filed 
might be lesser than the actual one. Some people may 
argue against the use of Scopus for data retrieval. How-
ever, Scopus is comprehensive, accurate, and suitable for 
bibliometric studies [61].
Conclusions
There was a dramatic increase in number of publications 
on carbapenem resistance in the last decade suggestive 
of serious spread of carbapenem resistance worldwide. 
Publications on carbapenem resistance originated from 
different world regions including Asia, Europe, and Latin 
America. The bulk of retrieved articles were published in 
microbiology and in journals related to infection control. 
These journals have high IF suggestive of clinical impor-
tance of this topic. International collaboration is impor-
tant and need to be adopted by researchers in Asian 
countries to increase citations and readability. Molecular 
biology of genes responsible for carbapenem resistance 
and epidemiology of this problem dominated the top ten 
cited articles on this topic.
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